{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:47:34Z","timestamp":1777884454808,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006389","name":"Universit\u00e9 de Gen\u00e8ve","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/27\/N\/NZ7\/02473"],"award-info":[{"award-number":["2017\/27\/N\/NZ7\/02473"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/33\/B\/NZ7\/02818"],"award-info":[{"award-number":["2019\/33\/B\/NZ7\/02818"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["964117C"],"award-info":[{"award-number":["964117C"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bmc.2023.117482","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:24:21Z","timestamp":1695342261000},"page":"117482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7863-6146","authenticated-orcid":false,"given":"Anna K.","family":"Puszko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4261-269X","authenticated-orcid":false,"given":"Piotr","family":"Sosnowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Hopfgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7746-5170","authenticated-orcid":false,"given":"Yves","family":"Lepelletier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Misicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117482_b0005","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0092-8674(00)80534-6","article-title":"Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III","volume":"90","author":"He","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2023.117482_b0010","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1042\/BST20110697","article-title":"How Neuropilin-1 Regulates Receptor Tyrosine Kinase Signalling: The Knowns and Known Unknowns","volume":"39","author":"Zachary","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.bmc.2023.117482_b0015","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/cancers3021899","article-title":"Neuropilins: A New Target for Cancer Therapy","volume":"3","author":"Grandclement","year":"2011","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.bmc.2023.117482_b0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.yexcr.2005.11.024","article-title":"Neuropilins in Neoplasms: Expression, Regulation, and Function","volume":"312","author":"Bielenberg","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.bmc.2023.117482_b0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.18632\/oncotarget.626","article-title":"Neuropilins Are Multifunctional Coreceptors Involved in Tumor Initiation, Growth, Metastasis and Immunity","volume":"3","author":"Prud\u2019homme","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2023.117482_b0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2613.2012.00810.x","article-title":"Neuropilins: Expression and Roles in the Epithelium","volume":"93","author":"Wild","year":"2012","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.bmc.2023.117482_b0035","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1073\/pnas.162366299","article-title":"Neuropilin-1 Is Required for Vascular Development and Is a Mediator of VEGF-Dependent Angiogenesis in Zebrafish","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2023.117482_b0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/path.2182","article-title":"Neuropilins in Physiological and Pathological Angiogenesis","volume":"212","author":"Staton","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.bmc.2023.117482_b0045","doi-asserted-by":"crossref","first-page":"24818","DOI":"10.1074\/jbc.M200730200","article-title":"Neuropilin-1 Binds Vascular Endothelial Growth Factor 165, Placenta Growth Factor-2, and Heparin via Its B1b2 Domain","volume":"277","author":"Mamluk","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0050","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bmc.2023.117482_b0055","doi-asserted-by":"crossref","first-page":"29120","DOI":"10.1074\/jbc.R115.687327","article-title":"Neuropilin Functions as an Essential Cell Surface Receptor","volume":"290","author":"Guo","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0060","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1096\/fj.00-0250com","article-title":"Neuropilin-1 Expression by Tumor Cells Promotes Tumor Angiogenesis and Progression","volume":"14","author":"Miao","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2023.117482_b0065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0092-8674(00)81402-6","article-title":"Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor","volume":"92","author":"Soker","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2023.117482_b0070","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1021\/jm901755g","article-title":"Small Molecule Inhibitors of the Neuropilin-1 Vascular Endothelial Growth Factor A (VEGF-A) Interaction","volume":"53","author":"Jarvis","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0075","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1016\/j.bmc.2010.03.012","article-title":"Sugar-Based Peptidomimetics as Potential Inhibitors of the Vascular Endothelium Growth Factor Binding to Neuropilin-1","volume":"18","author":"Novoa","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.canlet.2014.04.004","article-title":"Structure-Based Discovery of a Small Non-Peptidic Neuropilins Antagonist Exerting in Vitro and in Vivo Anti-Tumor Activity on Breast Cancer Model","volume":"349","author":"Borriello","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2023.117482_b0085","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1016\/j.bmc.2014.05.068","article-title":"Discovery of Novel Inhibitors of Vascular Endothelial Growth Factor-A\u2013Neuropilin-1 Interaction by Structure-Based Virtual Screening","volume":"22","author":"Starzec","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0090","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1016\/j.bmcl.2014.07.028","article-title":"Synthesis and Structure-Activity Relationship of Non-Peptidic Antagonists of Neuropilin-1 Receptor","volume":"24","author":"Liu","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117482_b0095","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1016\/j.bmc.2016.08.052","article-title":"Carbohydrate-Based Peptidomimetics Targeting Neuropilin-1: Synthesis, Molecular Docking Study and in Vitro Biological Activities","volume":"24","author":"Richard","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2017.10.039","article-title":"NRPa-308, a New Neuropilin-1 Antagonist, Exerts in Vitro Anti-Angiogenic and Anti-Proliferative Effects and in Vivo Anti-Cancer Effects in a Mouse Xenograft Model","volume":"414","author":"Liu","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2023.117482_b0105","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1021\/acs.jmedchem.8b00210","article-title":"Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGF\u03b2) Production in Regulatory T-Cells","volume":"61","author":"Powell","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126710","article-title":"Synthesis, 3D-Structure and Stability Analyses of NRPa-308, a New Promising Anti-Cancer Agent","volume":"29","author":"Brachet","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117482_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115183","article-title":"Discovery of Novel Nonpeptide Small-Molecule NRP1 Antagonists: Virtual Screening, Molecular Simulation and Structural Modification","volume":"28","author":"Peng","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0120","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/emboj\/19.7.1525","article-title":"Identification of a Peptide Blocking Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis","volume":"19","author":"Binetruy-Tournaire","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.bmc.2023.117482_b0125","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1074\/jbc.M511941200","article-title":"Tuftsin Binds Neuropilin-1 through a Sequence Similar to That Encoded by Exon 8 of Vascular Endothelial Growth Factor","volume":"281","author":"von Wronski","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0130","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.lfs.2006.08.005","article-title":"Antiangiogenic and Antitumor Activities of Peptide Inhibiting the Vascular Endothelial Growth Factor Binding to Neuropilin-1","volume":"79","author":"Starzec","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2023.117482_b0135","doi-asserted-by":"crossref","first-page":"13493","DOI":"10.1074\/jbc.M512121200","article-title":"Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling","volume":"281","author":"Jia","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0140","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.peptides.2007.09.013","article-title":"Structure-Function Analysis of the Antiangiogenic ATWLPPR Peptide Inhibiting VEGF165 Binding to Neuropilin-1 and Molecular Dynamics Simulations of the ATWLPPR\/Neuropilin-1 Complex","volume":"28","author":"Starzec","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.bmc.2023.117482_b0145","doi-asserted-by":"crossref","first-page":"16157","DOI":"10.1073\/pnas.0908201106","article-title":"C-End Rule Peptides Mediate Neuropilin-1-Dependent Cell, Vascular, and Tissue Penetration","volume":"106","author":"Teesalu","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2023.117482_b0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jsb.2013.02.006","article-title":"Sequence Dependence of C-End Rule Peptides in Binding and Activation of Neuropilin-1 Receptor","volume":"182","author":"Zanuy","year":"2013","journal-title":"J Struct Biol"},{"key":"10.1016\/j.bmc.2023.117482_b0155","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/cbic.201300658","article-title":"N-Terminal Modification of VEGF-A C Terminus-Derived Peptides Delineates Structural Features Involved in Neuropilin-1 Binding and Functional Activity","volume":"15","author":"Jia","year":"2014","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmc.2023.117482_b0160","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.bmcl.2016.04.059","article-title":"Design, Synthesis and in Vitro Biological Evaluation of a Small Cyclic Peptide as Inhibitor of Vascular Endothelial Growth Factor Binding to Neuropilin-1","volume":"26","author":"Grabowska","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117482_b0165","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bmc.2016.11.024","article-title":"Structure-Activity Relationship Study of a Small Cyclic Peptide H-c[Lys-Pro-Glu]-Arg-OH: A Potent Inhibitor of Vascular Endothelial Growth Factor Interaction with Neuropilin-1","volume":"25","author":"Grabowska","year":"2017","journal-title":"Bioorganic Med. Chem."},{"key":"10.1016\/j.bmc.2023.117482_b0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.peptides.2017.06.003","article-title":"Structure-Activity Relationship Study of Tetrapeptide Inhibitors of the Vascular Endothelial Growth Factor A Binding to Neuropilin-1","volume":"94","author":"Tymecka","year":"2017","journal-title":"Peptides"},{"key":"10.1016\/j.bmc.2023.117482_b0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/07391102.2015.1131196","article-title":"Molecular Modelling, Synthesis and Biological Evaluation of Peptide Inhibitors as Anti-Angiogenic Agent Targeting Neuropilin-1 for Anticancer Application","volume":"35","author":"Kamarulzaman","year":"2017","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2023.117482_b0180","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/psc.3009","article-title":"Conformational Latitude \u2013 Activity Relationship of KPPR Tetrapeptide Analogues toward Their Ability to Inhibit Binding of Vascular Endothelial Growth Factor 165 to Neuropilin-1","volume":"23","author":"Fedorczyk","year":"2017","journal-title":"J Pept Sci"},{"key":"10.1016\/j.bmc.2023.117482_b0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejmech.2018.08.083","article-title":"Branched Pentapeptides as Potent Inhibitors of the Vascular Endothelial Growth Factor 165 Binding to Neuropilin-1: Design, Synthesis and Biological Activity","volume":"158","author":"Tymecka","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24091756","article-title":"Triazolopeptides Inhibiting the Interaction between Neuropilin-1 and Vascular Endothelial Growth Factor-165","volume":"24","author":"Fedorczyk","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117482_b0195","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1039\/C8MD00537K","article-title":"Neuropilin-1 Peptide-like Ligands with Proline Mimetics, Tested Using the Improved Chemiluminescence Affinity Detection Method","volume":"10","author":"Puszko","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bmc.2023.117482_b0200","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.bmcl.2019.07.016","article-title":"Urea Moiety as Amide Bond Mimetic in Peptide-like Inhibitors of VEGF-A165\/NRP-1 Complex","volume":"29","author":"Puszko","year":"2019","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.bmc.2023.117482_b0205","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/biom10030448","article-title":"Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine","volume":"10","author":"Puszko","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmc.2023.117482_b0210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/ijms22010072","article-title":"Urea-Peptide Hybrids as VEGF-A165\/NRP-1 Complex Inhibitors with Improved Receptor Affinity and Biological Properties","volume":"22","author":"Puszko","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117482_b0215","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in Life, Disease and Medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117482_b0220","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd1226","article-title":"Therapeutic Angiogenesis in Cardiovascular Disease","volume":"2","author":"Simons","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2023.117482_b0225","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/1389450043345371","article-title":"Development of New Drugs in Angiogenesis","volume":"5","author":"Ziche","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bmc.2023.117482_b0230","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1038\/ncomms7240","article-title":"Neuropilin 1 Is an Entry Factor That Promotes EBV Infection of Nasopharyngeal Epithelial Cells","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2023.117482_b0235","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1128\/JVI.02719-05","article-title":"Neuropilin-1 Is Involved in Human T-Cell Lymphotropic Virus Type 1 Entry","volume":"80","author":"Ghez","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2023.117482_b0240","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1182\/blood-2008-04-150342","article-title":"HTLV-1 Uses HSPG and Neuropilin-1 for Entry by Molecular Mimicry of VEGF165","volume":"113","author":"Lambert","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2023.117482_b0245","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.abd3072","article-title":"Neuropilin-1 Is a Host Factor for SARS-CoV-2 Infection","volume":"370","author":"Daly","year":"2020","journal-title":"Science (80-.)"},{"key":"10.1016\/j.bmc.2023.117482_b0250","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 Facilitates SARS-CoV-2 Cell Entry and Infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science (80-.)"},{"key":"10.1016\/j.bmc.2023.117482_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116537","article-title":"Molecular Basis of the New COVID-19 Target Neuropilin-1 in Complex with SARS-CoV-2 S1 C-End Rule Peptide and Small-Molecule Antagonists","volume":"335","author":"Klaewkla","year":"2021","journal-title":"J Mol Liq"},{"key":"10.1016\/j.bmc.2023.117482_b0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10989-014-9436-6","article-title":"New Peptides Structurally Related to VEGF-A165 Exon-7 and -8 Encoded Domains Antagonize Its Binding to NRP-1 and VEGF-R1","volume":"21","author":"Liu","year":"2015","journal-title":"Int J Pept Res Ther"},{"key":"10.1016\/j.bmc.2023.117482_b0265","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1021\/jo00795a005","article-title":"The 9-Fluorenylmethoxycarbonyl Amino-Protecting Group","volume":"37","author":"Carpino","year":"1972","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0270","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/psc.921","article-title":"Fast Conventional Fmoc Solid-Phase Peptide Synthesis with HCTU","volume":"14","author":"Hood","year":"2008","journal-title":"J Pept Sci"},{"key":"10.1016\/j.bmc.2023.117482_b0275","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.sbi.2006.01.013","article-title":"Can We Rationally Design Promiscuous Drugs?","volume":"16","author":"Hopkins","year":"2006","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.bmc.2023.117482_b0280","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/jm2010332","article-title":"Rational Approaches to Improving Selectivity in Drug Design","volume":"55","author":"Huggins","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0285","doi-asserted-by":"crossref","first-page":"25110","DOI":"10.1074\/jbc.C800137200","article-title":"Neuropilin-1-VEGFR-2 Complexing Requires the PDZ-Binding Domain of Neuropilin-1","volume":"283","author":"Prahst","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0290","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/geno.2000.6381","article-title":"Genomic Organization of Human Neuropilin-1 and Neuropilin-2 Genes: Identification and Distribution of Splice Variants and Soluble Isoforms","volume":"70","author":"Rossignol","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.bmc.2023.117482_b0295","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BJ20071639","article-title":"Neuropilins: Structure, Function and Role in Disease","volume":"411","author":"Pellet-Many","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2023.117482_b0300","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.1073\/pnas.94.14.7192","article-title":"Vascular Endothelial Growth Factor: Crystal Structure and Functional Mapping of the Kinase Domain Receptor Binding Site","volume":"94","author":"Muller","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2023.117482_b0305","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/ijms19041264","article-title":"Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2","volume":"19","author":"Peach","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117482_b0310","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1073\/pnas.0700043104","article-title":"Structural Basis for Ligand and Heparin Binding to Neuropilin B Domains","volume":"104","author":"Vander Kooi","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2023.117482_b0315","doi-asserted-by":"crossref","unstructured":"Dal, JL, Simonetti B, Klein K, Chen K-E, Williamson MK, Ant\u00f3n-Pl\u00e1garo C, Shoemark DK, Sim\u00f3n-Gracia L, Bauer M, Hollandi, R.; et al. Neuropilin-1 Is a Host Factor for SARS-CoV-2 Infection. Science (80-.). 2020, 370 (6518), 861\u2013865. Doi: 10.1126\/science.abd3072.","DOI":"10.1126\/science.abd3072"},{"key":"10.1016\/j.bmc.2023.117482_b0320","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202100463","article-title":"Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1","volume":"23","author":"Mota","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmc.2023.117482_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2018.10.014","article-title":"SWATH Data Independent Acquisition Mass Spectrometry for Metabolomics","volume":"120","author":"Bonner","year":"2019","journal-title":"TrAC Trends Anal Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0330","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1007\/s00216-019-01946-4","article-title":"Hybrid SWATH\/MS and HR-SRM\/MS Acquisition for Phospholipidomics Using QUAL\/QUANT Data Processing","volume":"411","author":"Raetz","year":"2019","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0335","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.aca.2020.06.030","article-title":"Automated Parallel Derivatization of Metabolites with SWATH-MS Data Acquisition for Qualitative and Quantitative Analysis","volume":"1127","author":"Cifuentes Girard","year":"2020","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.bmc.2023.117482_b0340","doi-asserted-by":"crossref","unstructured":"Mansfeld MF, Toth I. Synthesis and Plasma Stability of Disulfide-Bridged Cyclic Endomorphin-1 Derivatives. Int. J. Org. Chem. 2012, 02 (01), 1\u20136. Doi: 10.4236\/ijoc.2012.21001.","DOI":"10.4236\/ijoc.2012.21001"},{"key":"10.1016\/j.bmc.2023.117482_b0345","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1210\/en.2004-0569","article-title":"Ghrelin Degradation by Serum and Tissue Homogenates: Identification of the Cleavage Sites","volume":"145","author":"De Vriese","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bmc.2023.117482_b0350","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.peptides.2005.06.015","article-title":"Enzymatic Degradation Studies of Endomorphin-2 and Its Analogs Containing N-Methylated Amino Acids","volume":"27","author":"Janecka","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.bmc.2023.117482_b0355","doi-asserted-by":"crossref","first-page":"e12684","DOI":"10.1371\/journal.pone.0012684","article-title":"Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs","volume":"5","author":"Nguyen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117482_b0360","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/AAC.00976-09","article-title":"An Albumin-Conjugated Peptide Exhibits Potent Anti-HIV Activity and Long In Vivo Half-Life","volume":"54","author":"Xie","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117482_b0365","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tifs.2010.03.003","article-title":"Food Applications of Liposome-Encapsulated Antimicrobial Peptides","volume":"21","author":"da Silva Malheiros","year":"2010","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.bmc.2023.117482_b0370","first-page":"5","article-title":"Dual Coating of Liposomes as Encapsulating Matrix of Antimicrobial Peptides: Development and Characterization","author":"Gomaa","year":"2017","journal-title":"Front Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0375","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1021\/bm500169p","article-title":"Drug Carriers for the Delivery of Therapeutic Peptides","volume":"15","author":"Du","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bmc.2023.117482_b0380","doi-asserted-by":"crossref","unstructured":"Cao Y, Hoeppner LH, Bach SEG, Guo Y, Wang E, Wu J, Cowley MJ, Chang DK, Waddell N, et al. Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial \u03915 Integrin. Cancer Res. 2013, 73 (14), 4579\u20134590. Doi: 10.1158\/0008-5472.CAN-13-0529.","DOI":"10.1158\/0008-5472.CAN-13-0529"},{"key":"10.1016\/j.bmc.2023.117482_b0385","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High Performance Molecular Simulations through Multi-Level Parallelism from Laptops to Supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.bmc.2023.117482_b0390","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM Simulations Using the CHARMM36 Additive Force Field","volume":"12","author":"Lee","year":"2016","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2023.117482_b0395","doi-asserted-by":"crossref","first-page":"D327","DOI":"10.1093\/nar\/gks991","article-title":"SwissSidechain: A Molecular and Structural Database of Non-Natural Sidechains","volume":"41","author":"Gfeller","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2023.117482_b0400","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera?A Visualization System for Exploratory Research and Analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0405","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.bmc.2006.12.007","article-title":"Endomorphin-1 Analogs with Enhanced Metabolic Stability and Systemic Analgesic Activity: Design, Synthesis, and Pharmacological Characterization","volume":"15","author":"Liu","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117482_b0410","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.3390\/molecules181214564","article-title":"Insights into Structure-Activity Relationships of Somatostatin Analogs Containing Mesitylalanine","volume":"18","author":"Mart\u00edn-Gago","year":"2013","journal-title":"Molecules"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:25:53Z","timestamp":1777602353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623003309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":82,"alternative-id":["S0968089623003309"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117482","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117482"}}